Drossman D A, Whitehead W E, Toner B B, Diamant N, Hu Y J, Bangdiwala S I, Jia H
UNC Center for Functional GI and Motility Disorders, Division of Digestive Diseases, University of North Carolina, Chapel Hill 27599-7080, USA.
Am J Gastroenterol. 2000 Apr;95(4):974-80. doi: 10.1111/j.1572-0241.2000.01936.x.
For patients with painful functional bowel disorders (FBD), physicians frequently make diagnostic and treatment decisions based on the severity of the pain reported; patients with severe painful complaints may receive extensive diagnostic tests and treatments. Therefore, it would be important to determine what clinical factors contribute to the judgment of severity among patients with FBD. The aim of this study was to identify the psychosocial, behavioral, and physiological (visceral sensitivity) factors that predicted severity in patients with moderate to severe FBD.
Two hundred eleven female patients with moderate or severe FBD, as determined by the Functional Bowel Disorder Severity Index, entered a multicenter treatment trial at the University of North Carolina and the University of Toronto. Patients filled out diary cards and were given questionnaires and physiological testing (rectal sensitivity using barostat). Analysis of covariance and logistic regression adjusting for demographic factors were performed to determine which factors distinguished patients at study entry with moderate from those with severe FBD.
Patients with severe FBD were characterized by greater depression and psychological distress, poorer physical functioning and health-related quality of life, more maladaptive coping strategies, and greater health care utilization. There was a trend for patients with severe FBD to have lower rectal sensation thresholds. Regression analysis indicated that severity was best predicted by behavioral features: poorer daily physical function, difficulties related to eating, more phone calls to the physician, and more days in bed for GI symptoms.
We conclude that patient illness behaviors are best correlated with severity in FBD. The use of psychopharmacological agents (e.g., antidepressants) and psychological treatments to treat psychiatric comorbidity and to improve behavioral coping styles is recommended. Training to help medical physicians identify and respond to psychosocial and behavioral features of these conditions is likely to improve patient satisfaction with their care and the clinical outcome.
对于患有疼痛性功能性肠病(FBD)的患者,医生常常根据患者报告的疼痛严重程度做出诊断和治疗决策;疼痛严重的患者可能会接受广泛的诊断检查和治疗。因此,确定哪些临床因素会影响FBD患者的严重程度判断非常重要。本研究的目的是识别预测中度至重度FBD患者严重程度的心理社会、行为和生理(内脏敏感性)因素。
根据功能性肠病严重程度指数确定的211名中度或重度FBD女性患者,进入北卡罗来纳大学和多伦多大学的一项多中心治疗试验。患者填写日记卡,并接受问卷调查和生理测试(使用恒压器测量直肠敏感性)。进行协方差分析和对人口统计学因素进行调整的逻辑回归分析,以确定哪些因素能区分入组时中度FBD患者和重度FBD患者。
重度FBD患者的特点是抑郁和心理困扰更严重、身体功能和与健康相关的生活质量较差、应对策略更不适应以及医疗保健利用率更高。重度FBD患者的直肠感觉阈值有降低的趋势。回归分析表明,严重程度最好由行为特征预测:日常身体功能较差、饮食相关困难、给医生打电话更多以及因胃肠道症状卧床天数更多。
我们得出结论,患者的疾病行为与FBD的严重程度最相关。建议使用心理药物(如抗抑郁药)和心理治疗来治疗精神共病并改善行为应对方式。帮助医生识别并应对这些情况的心理社会和行为特征的培训,可能会提高患者对医疗护理的满意度和临床结局。